Lefty1 alleviates renal tubulointerstitial injury in mice with unilateral ureteral obstruction

Xu,Changgeng; Xu,Mingwei; Wang,Wei; Zhang,Jie

doi:10.3892/mmr.2015.4631

Lefty1 alleviates renal tubulointerstitial injury in mice with unilateral ureteral obstruction

Authors:
- Changgeng Xu
- Mingwei Xu
- Wei Wang
- Jie Zhang
View Affiliations

Affiliations: Department of Urology, Wuhan Central Hospital, Wuhan, Hubei 430014, P.R. China, Department of Urology, Xiangyang Central Hospital, Xiangyang, Hubei 441021, P.R. China, Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: November 30, 2015 https://doi.org/10.3892/mmr.2015.4631
Pages: 901-908

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lefty is a member of the transforming growth factor (TGF) β superfamily, which is implicated in left‑right patterning during embryogenesis. Previous studies revealed that lefty attenuates the epithelial‑mesenchymal transition in tubular epithelial cells. In the present study, the protective effect of lefty1 on renal interstitial injury was further assessed. Mice with a unilateral ureteral obstruction (UUO) were sacrificed on days 3, 5 and 7 following surgery, and the association between the expression of lefty1 and the degree of interstitial fibrosis was investigated. Subsequently, mice with a UUO were administered recombinant lefty1 (300 µg/kg body weight) or vehicle (0.9% saline solution; 100 µl) through tail‑vein injection every other day for 6 days. The effects of lefty1 were assessed by measuring the degree of tubulointerstitial fibrosis, tubular injury and atrophy, and also by monitoring the expression levels of α‑smooth muscle actin (α‑SMA), TGF‑β1, phosphorylated (p)‑Smad2/3, kidney injury molecular‑1 and endogenous lefty1. The expression of lefty1 in the kidney decreased in a time‑dependent manner in mice with a UUO, which was inversely correlated with the degree of renal interstitial fibrosis. Furthermore, compared with vehicle treatment, lefty1 attenuated renal interstitial fibrosis. Ureteral ligation induced increased expression levels of α‑SMA, TGF‑β1 and p‑Smad2/3. However, these effects were reduced following treatment with lefty1. The UUO also induced tubular injury and atrophy, whereas lefty1 treatment exerted a marked suppressive effect on tubular injury. In addition, exogenous lefty1 administered to mice restored the endogenous expression levels of lefty1. The present study demonstrated that lefty1 attenuated renal interstitial injury by inhibiting the Smad‑dependent TGF‑β1 signaling pathway. Lefty1 may therefore by a putative therapeutic agent in the treatment of renal injury.

View Figures

View References

1	Meguid El, Nahas A and Bello AK: Chronic kidney disease: The global challenge. Lancet. 365:331–340. 2005. View Article : Google Scholar
2	Barnes JL and Glass WF II: Renal interstitial fibrosis: A critical evaluation of the origin of myofibroblasts. Contrib Nephrol. 169:73–93. 2011. View Article : Google Scholar : PubMed/NCBI
3	Chuang PY, Menon MC and He JC: Molecular targets for treatment of kidney fibrosis. J Mol Med (Berl). 91:549–559. 2013. View Article : Google Scholar
4	López-Hernández FJ and López-Novoa JM: Role of TGF-β in chronic kidney disease: An integration of tubular, glomerular and vascular effects. Cell Tissue Res. 347:141–154. 2012. View Article : Google Scholar
5	Gewin L and Zent R: How does TGF-β mediate tubulointerstitial fibrosis? Semin Nephrol. 32:228–235. 2012. View Article : Google Scholar : PubMed/NCBI
6	Koesters R, Kaissling B, Lehir M, Picard N, Theilig F, Gebhardt R, Glick AB, Hähnel B, Hosser H, Gröne HJ and Kriz W: Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol. 177:632–643. 2010. View Article : Google Scholar : PubMed/NCBI
7	Moon JA, Kim HT, Cho IS, Sheen YY and Kim DK: IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int. 70:1234–1243. 2006. View Article : Google Scholar : PubMed/NCBI
8	Douthwaite JA, Johnson TS, Haylor JL, Watson P and El Nahas AM: Effects of transforming growth factor-beta1 on renal extracellular matrix components and their regulating proteins. J Am Soc Nephrol. 10:2109–2119. 1999.PubMed/NCBI
9	García-Sánchez O, López-Hernández FJ and López-Novoa JM: An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int. 77:950–955. 2010. View Article : Google Scholar : PubMed/NCBI
10	Inazaki K, Kanamaru Y, Kojima Y, Sueyoshi N, Okumura K, Kaneko K, Yamashiro Y, Ogawa H and Nakao A: Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int. 66:597–604. 2004. View Article : Google Scholar : PubMed/NCBI
11	Kosaki K, Bassi MT, Kosaki R, Lewin M, Belmont J, Schauer G and Casey B: Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. Am J Hum Genet. 64:712–721. 1999. View Article : Google Scholar : PubMed/NCBI
12	Meno C, Ito Y, Saijoh Y, Matsuda Y, Tashiro K, Kuhara S and Hamada H: Two closely-related left-right asymmetrically expressed genes, lefty-1 and lefty-2: Their distinct expression domains, chromosomal linkage and direct neuralizing activity in Xenopus embryos. Genes Cells. 2:513–524. 1997. View Article : Google Scholar : PubMed/NCBI
13	Meno C, Saijoh Y, Fujii H, Ikeda M, Yokoyama T, Yokoyama M, Toyoda Y and Hamada H: Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. Nature. 381:151–155. 1996. View Article : Google Scholar : PubMed/NCBI
14	Ulloa L and Tabibzadeh S: Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-beta receptor. J Biol Chem. 276:21397–21404. 2001. View Article : Google Scholar : PubMed/NCBI
15	Mason JM, Xu HP, Rao SK, Leask A, Barcia M, Shan J, Stephenson R and Tabibzadeh S: Lefty contributes to the remodeling of extracellular matrix by inhibition of connective tissue growth factor and collagen mRNA expression and increased proteolytic activity in a fibrosarcoma model. J Biol Chem. 277:407–415. 2002. View Article : Google Scholar
16	Li Y, Zhang J, Fang L, Luo P, Peng J and Du X: Lefty A attenuates the TGF-beta1-induced epithelial to mesenchymal transition of human renal proximal epithelial tubular cells. Mol Cell Biochem. 339:263–270. 2010. View Article : Google Scholar : PubMed/NCBI
17	Mariasegaram M, Tesch GH, Verhardt S, Hurst L, Lan HY and Nikolic-Paterson DJ: Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells. Biochem Biophys Res Commun. 393:855–859. 2010. View Article : Google Scholar : PubMed/NCBI
18	Sorensen I, Susnik N, Inhester T, Degen JL, Melk A, Haller H and Schmitt R: Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int. 80:1035–1044. 2011. View Article : Google Scholar : PubMed/NCBI
19	Li L, Zepeda-Orozco D, Black R and Lin F: Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol. 176:1767–1778. 2010. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
21	Tang M, Xu Y, Julian J, Carson D and Tabibzadeh S: Lefty is expressed in mouse endometrium in estrous cycle and peri-implantation period. Hum Reprod. 20:872–880. 2005. View Article : Google Scholar : PubMed/NCBI
22	Tabibzadeh S and Hemmati-Brivanlou A: Lefty at the crossroads of ʻstemness' and differentiative events. Stem Cells. 24:1998–2006. 2006. View Article : Google Scholar : PubMed/NCBI
23	Besser D: Expression of nodal, lefty-a and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem. 279:45076–45084. 2004. View Article : Google Scholar : PubMed/NCBI
24	Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, et al: Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 58:2301–2313. 2000. View Article : Google Scholar : PubMed/NCBI
25	Cornet PB, Galant C, Eeckhout Y, Courtoy PJ, Marbaix E and Henriet P: Regulation of matrix metallopro-teinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium. J Clin Endocrinol Metab. 90:1001–1011. 2005. View Article : Google Scholar
26	Zhang YE: Non-Smad pathways in TGF-beta signaling. Cell Res. 19:128–139. 2009. View Article : Google Scholar :
27	Lan HY: Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067. 2011. View Article : Google Scholar